Correction to: Comparative Effectiveness and Tolerability of the Pharmacology of Monoclonal Antibodies Targeting the Calcitonin Gene-Related Peptide and Its Receptor for the Prevention of Chronic Migraine: a Network Meta-analysis of Randomized Controlled Trials (Neurotherapeutics, (2021), 18, 4, (2639-2650), 10.1007/s13311-021-01128-0)

Chun Pai Yang; Bing Yan Zeng; Ching Mao Chang; Po Hsuan Shih; Cheng Chia Yang; Ping Tao Tseng; Shuu Jiun Wang

doi:10.1007/s13311-021-01135-1

Correction to: Comparative Effectiveness and Tolerability of the Pharmacology of Monoclonal Antibodies Targeting the Calcitonin Gene-Related Peptide and Its Receptor for the Prevention of Chronic Migraine: a Network Meta-analysis of Randomized Controlled Trials (Neurotherapeutics, (2021), 18, 4, (2639-2650), 10.1007/s13311-021-01128-0)

Chun Pai Yang, Bing Yan Zeng, Ching Mao Chang, Po Hsuan Shih, Cheng Chia Yang, Ping Tao Tseng, Shuu Jiun Wang^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate

Abstract

The original version of this article was revised to add a second affiliation “Division of Endocrinology & Metabolism, Department of Internal Medicine, E-DA Dachang Hospital, Kaohsiung, Taiwan” to author Bing-Yan Zeng. The Original article has been corrected.

Original language	English
Pages (from-to)	2755
Number of pages	1
Journal	Neurotherapeutics
Volume	18
Issue number	4
DOIs	https://doi.org/10.1007/s13311-021-01135-1
State	E-pub ahead of print - Oct 2021

Access to Document

10.1007/s13311-021-01135-1

Fingerprint

Dive into the research topics of 'Correction to: Comparative Effectiveness and Tolerability of the Pharmacology of Monoclonal Antibodies Targeting the Calcitonin Gene-Related Peptide and Its Receptor for the Prevention of Chronic Migraine: a Network Meta-analysis of Randomized Controlled Trials (Neurotherapeutics, (2021), 18, 4, (2639-2650), 10.1007/s13311-021-01128-0)'. Together they form a unique fingerprint.

Cite this

Yang, C. P., Zeng, B. Y., Chang, C. M., Shih, P. H., Yang, C. C., Tseng, P. T., & Wang, S. J. (2021). Correction to: Comparative Effectiveness and Tolerability of the Pharmacology of Monoclonal Antibodies Targeting the Calcitonin Gene-Related Peptide and Its Receptor for the Prevention of Chronic Migraine: a Network Meta-analysis of Randomized Controlled Trials (Neurotherapeutics, (2021), 18, 4, (2639-2650), 10.1007/s13311-021-01128-0). Neurotherapeutics, 18(4), 2755. Advance online publication. https://doi.org/10.1007/s13311-021-01135-1

Yang, Chun Pai ; Zeng, Bing Yan ; Chang, Ching Mao et al. / Correction to : Comparative Effectiveness and Tolerability of the Pharmacology of Monoclonal Antibodies Targeting the Calcitonin Gene-Related Peptide and Its Receptor for the Prevention of Chronic Migraine: a Network Meta-analysis of Randomized Controlled Trials (Neurotherapeutics, (2021), 18, 4, (2639-2650), 10.1007/s13311-021-01128-0). In: Neurotherapeutics. 2021 ; Vol. 18, No. 4. pp. 2755.

@article{b1db408b1e3245aab45e88c0cb0dc699,

title = "Correction to: Comparative Effectiveness and Tolerability of the Pharmacology of Monoclonal Antibodies Targeting the Calcitonin Gene-Related Peptide and Its Receptor for the Prevention of Chronic Migraine: a Network Meta-analysis of Randomized Controlled Trials (Neurotherapeutics, (2021), 18, 4, (2639-2650), 10.1007/s13311-021-01128-0)",

abstract = "The original version of this article was revised to add a second affiliation “Division of Endocrinology & Metabolism, Department of Internal Medicine, E-DA Dachang Hospital, Kaohsiung, Taiwan” to author Bing-Yan Zeng. The Original article has been corrected.",

author = "Yang, {Chun Pai} and Zeng, {Bing Yan} and Chang, {Ching Mao} and Shih, {Po Hsuan} and Yang, {Cheng Chia} and Tseng, {Ping Tao} and Wang, {Shuu Jiun}",

note = "Publisher Copyright: {\textcopyright} The American Society for Experimental NeuroTherapeutics, Inc. 2021",

year = "2021",

month = oct,

doi = "10.1007/s13311-021-01135-1",

language = "English",

volume = "18",

pages = "2755",

journal = "Neurotherapeutics",

issn = "1933-7213",

publisher = "Springer New York",

number = "4",

}

Yang, CP, Zeng, BY, Chang, CM, Shih, PH, Yang, CC, Tseng, PT & Wang, SJ 2021, 'Correction to: Comparative Effectiveness and Tolerability of the Pharmacology of Monoclonal Antibodies Targeting the Calcitonin Gene-Related Peptide and Its Receptor for the Prevention of Chronic Migraine: a Network Meta-analysis of Randomized Controlled Trials (Neurotherapeutics, (2021), 18, 4, (2639-2650), 10.1007/s13311-021-01128-0)', Neurotherapeutics, vol. 18, no. 4, pp. 2755. https://doi.org/10.1007/s13311-021-01135-1

Correction to: Comparative Effectiveness and Tolerability of the Pharmacology of Monoclonal Antibodies Targeting the Calcitonin Gene-Related Peptide and Its Receptor for the Prevention of Chronic Migraine: a Network Meta-analysis of Randomized Controlled Trials (Neurotherapeutics, (2021), 18, 4, (2639-2650), 10.1007/s13311-021-01128-0). / Yang, Chun Pai; Zeng, Bing Yan; Chang, Ching Mao et al.
In: Neurotherapeutics, Vol. 18, No. 4, 10.2021, p. 2755.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - Comparative Effectiveness and Tolerability of the Pharmacology of Monoclonal Antibodies Targeting the Calcitonin Gene-Related Peptide and Its Receptor for the Prevention of Chronic Migraine: a Network Meta-analysis of Randomized Controlled Trials (Neurotherapeutics, (2021), 18, 4, (2639-2650), 10.1007/s13311-021-01128-0)

AU - Yang, Chun Pai

AU - Zeng, Bing Yan

AU - Chang, Ching Mao

AU - Shih, Po Hsuan

AU - Yang, Cheng Chia

AU - Tseng, Ping Tao

AU - Wang, Shuu Jiun

PY - 2021/10

Y1 - 2021/10

N2 - The original version of this article was revised to add a second affiliation “Division of Endocrinology & Metabolism, Department of Internal Medicine, E-DA Dachang Hospital, Kaohsiung, Taiwan” to author Bing-Yan Zeng. The Original article has been corrected.

AB - The original version of this article was revised to add a second affiliation “Division of Endocrinology & Metabolism, Department of Internal Medicine, E-DA Dachang Hospital, Kaohsiung, Taiwan” to author Bing-Yan Zeng. The Original article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85116463905&partnerID=8YFLogxK

U2 - 10.1007/s13311-021-01135-1

DO - 10.1007/s13311-021-01135-1

M3 - Comment/debate

C2 - 34617266

AN - SCOPUS:85116463905

SN - 1933-7213

VL - 18

SP - 2755

JO - Neurotherapeutics

JF - Neurotherapeutics

IS - 4

ER -

Yang CP, Zeng BY, Chang CM, Shih PH, Yang CC, Tseng PT et al. Correction to: Comparative Effectiveness and Tolerability of the Pharmacology of Monoclonal Antibodies Targeting the Calcitonin Gene-Related Peptide and Its Receptor for the Prevention of Chronic Migraine: a Network Meta-analysis of Randomized Controlled Trials (Neurotherapeutics, (2021), 18, 4, (2639-2650), 10.1007/s13311-021-01128-0). Neurotherapeutics. 2021 Oct;18(4):2755. Epub 2021 Oct. doi: 10.1007/s13311-021-01135-1

Abstract

Access to Document

Other files and links

Fingerprint

Cite this